EUVIMEDEUVIMED entdecken
Crossref

Targeting SPI1 to mitigate amyloid-β pathology in Alzheimer's disease

Jie Shao iD, Hannah Youngblood iD, Luodan Yang iD

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251316593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Jie Shao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Physical Education and Sports Science, South China Normal University, Guangzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Trans-Activators. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SPI1, a transcription factor implicated in myeloid cell development, has emerged as a genetic risk factor for Alzheimer's disease (AD). Recent in vivo studies reveal that Spi1 knockdown in mice exacerbates AD pathology by increasing amyloid-β aggregation and gliosis while Spi1 overexpression ameliorates these features. Transcriptomic analyses suggest that Spi1 regulates microglial immune response, complement activation, and phagocytosis. SPI1 regulation of these processes may explain how SPI1 affects AD risk. Further studies, including human validation, are needed to explore the dynamic influence of SPI1 across AD stages, its applicability to clinical settings, and its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesTrans-ActivatorsAnimalsHumansMiceMicrogliaProto-Oncogene ProteinsProto-Oncogene Protein Spi-1

Stichwörter der Autor:innen

Alzheimer's diseaseSPI1amyloid-β aggregationgliosis

Substanzen

Amyloid beta-PeptidesTrans-ActivatorsProto-Oncogene ProteinsProto-Oncogene Protein Spi-1

Autor:innen und Institutionen

  • School of Physical Education and Sports Science, South China Normal University, Guangzhou, China.
  • School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA.

ORCID-Profile: Jie Shao, Hannah Youngblood, Luodan Yang

Zitieren

APA

Shao, J., Youngblood, H., & Yang, L. (2025). Targeting SPI1 to mitigate amyloid-β pathology in Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251316593

Vancouver

Shao J, Youngblood H, Yang L. Targeting SPI1 to mitigate amyloid-β pathology in Alzheimer's disease. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251316593

BibTeX
@article{Shao2025,
  author = {Shao, Jie and Youngblood, Hannah and Yang, Luodan},
  title = {Targeting SPI1 to mitigate amyloid-β pathology in Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251316593}
}
Kostenlos starten →